Advocacy Training
 

Scholarships are offered, also many Komen affiliates will also provide scholarships for this training.

http://www.stopbreastcancer.org/bin/...id=713&depid=5


Regards
Joe

HELLO JOE ,



Please , Can you sent me the percentage of the women HER2 - positivity who had been exposed to Herceptin in adjuvant treatment and developped reccurence after ?

From HERA study The break down of risk for relaspe in 2 yr. f/u is as follows for observation group :

ER,PR Negative, her2+
Node Negative 18%
1-3 nodes 25%
greater 4 nodes 33%

ER,PR positive, her2+
Node Negative 9%
1-3 Nodes 12%
greater 4 nodes 33%


but I d'ont find anyting for the group one year herceptin .


I look forward to your prompt reply ,
Thank you for your cooperation ..
Sincerely,
VIVIANE

The 2 year follow up figures will not be available for another year. The trials only ended last April.


Regards
Joe

HELLO JOE ,



What I want to khnow the percentage of the women HER2 - positivity who had been exposed to one year of Herceptin not 2 years of Herceptin in adjuvant treatment and developped reccurence after ?

From HERA study The break down of risk for relaspe is as follows for observation group after 2 years follow up .

ER,PR Negative, her2+
Node Negative 18%
1-3 nodes 25%
greater 4 nodes 33%

ER,PR positive, her2+
Node Negative 9%
1-3 Nodes 12%
greater 4 nodes 33%


but I d'ont find anyting for the group one year herceptin .


I look forward to your prompt reply ,
Thank you for your cooperation ..
Sincerely,
VIVIANE